Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scheifele

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|October 19, 2016
Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian ChildrenJulie A Bettinger, Otto G Vanderkooi, David W Scheifele, et al.
The Pediatric Infectious Disease Journal|December 24, 2010
Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young childrenDavid W Scheifele, Brian J Ward, Marc Dionne, et al.
Vaccine|April 28, 2012
Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: interim analysisJulie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|October 9, 2013
Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in CanadaKarina A Top, Cora M Constantinescu, Julie Laflèche, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Serious adverse events associated with bacille Calmette-Guérin vaccine in CanadaShelley L Deeks, Michael Clark, David W Scheifele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2003
Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adultsDavid W Scheifele, Bernard Duval, Margaret L Russell, et al.
The Pediatric Infectious Disease Journal|October 24, 2002
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control studyJames D Kellner, David W Scheifele, Scott A Halperin, et al.
The Pediatric Infectious Disease Journal|October 1, 2011
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in CanadaOtto G Vanderkooi, David W Scheifele, Douglas Girgenti, et al.
Clinical Immunology (Orlando, Fla.)|December 13, 2006
Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infectionAaron F Hirschfeld, Julie A Bettinger, Rachel E Victor, et al.
BMC Public Health|June 3, 2014
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigationAmy Schneeberg, Julie A Bettinger, Shelly McNeil, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|October 19, 2016
Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian ChildrenJulie A Bettinger, Otto G Vanderkooi, David W Scheifele, et al.
The Pediatric Infectious Disease Journal|December 24, 2010
Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young childrenDavid W Scheifele, Brian J Ward, Marc Dionne, et al.
Vaccine|April 28, 2012
Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: interim analysisJulie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|October 9, 2013
Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in CanadaKarina A Top, Cora M Constantinescu, Julie Laflèche, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Serious adverse events associated with bacille Calmette-Guérin vaccine in CanadaShelley L Deeks, Michael Clark, David W Scheifele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2003
Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adultsDavid W Scheifele, Bernard Duval, Margaret L Russell, et al.
The Pediatric Infectious Disease Journal|October 24, 2002
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control studyJames D Kellner, David W Scheifele, Scott A Halperin, et al.
The Pediatric Infectious Disease Journal|October 1, 2011
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in CanadaOtto G Vanderkooi, David W Scheifele, Douglas Girgenti, et al.
Clinical Immunology (Orlando, Fla.)|December 13, 2006
Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infectionAaron F Hirschfeld, Julie A Bettinger, Rachel E Victor, et al.
BMC Public Health|June 3, 2014
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigationAmy Schneeberg, Julie A Bettinger, Shelly McNeil, et al.
Pageof 8